Boehringer Ingelheim New Zealand - Latest News [Page 1]

PHARMAC Opens Consultation To Address New Zealand’s Biggest Health Issue

Wednesday, 9 September 2020, 2:30 pm | Boehringer Ingelheim New Zealand

Proposal to list type 2 diabetes medicine Jardiance® Boehringer Ingelheim New Zealand welcomes a major PHARMAC proposal2 which could see up to 50,000 New Zealanders with type 2 diabetes and high risk of heart and kidney complications receive funded access ... More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL